Oxytocin and therapist-client syncing during inpatient care
Treatments studied
Part of Mental health clinical trials.
This Phase 2 study tests whether giving oxytocin (a hormone sometimes studied for social and bonding effects) helps patients and therapists become more “physiologically synchronized” during inpatient psychiatric care. It compares responses in patients and therapists to see if this change is measurable and potentially helpful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have any diagnosed psychiatric illness.
- You are currently hospitalized in an inpatient psychiatric ward.
- You do not have a severe active psychotic episode right now.
- You are not pregnant (based on your self-report).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding oxytocin (a hormone that helps with social bonding) to group therapy can improve symptoms and social functioning in people with schizophrenia. It compares two different doses of oxytocin to see which works better.
This trial studies whether oxytocin, given alongside structured psycho-educational support, can be safe and feasible in helping children with autism and moderate-to-severe intellectual disability who have challenging behaviors. It focuses on whether the added treatment can work without unacceptable side effects.
This trial tests whether oxytocin, a hormone that helps with social bonding and stress, can improve anxiety or emotional awareness in people with central diabetes insipidus (a condition where the body can't regulate water balance). It may be a good fit if you have high anxiety or trouble identifying your feelings.
This study explores whether being with a friendly dog and getting a nasal spray of oxytocin (a natural hormone) can help you feel more trust toward a therapist. It's looking for healthy adults who are comfortable around dogs.
This Phase 2 study tests whether a nasal spray containing oxytocin can help youth with autism spectrum disorder. It focuses on participants who are healthy enough for the spray and able to follow study instructions, and it avoids people with certain nasal problems or allergies.
This early-phase study tests whether a spray of oxytocin in the nose can be given safely and may affect symptoms in people with arginine-vasopressin deficiency. You might qualify if your hormone levels are stable and you can safely take the nasal study medicine during the study period.
Hear when a new Severe Mental Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.